Nurse Assisted Post-discharge Intervention in Decompensated Cirrhosis
NurseAID
Post-discharge Nurse-driven Intervention Program for Patients With Decompensated Liver Cirrhosis
1 other identifier
interventional
110
1 country
1
Brief Summary
In a randomized controlled trial, the effects of a nurse-driven post-discharge intervention for patients with liver cirrhosis compared with standard follow-up will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2019
CompletedFirst Posted
Study publicly available on registry
November 12, 2019
CompletedStudy Start
First participant enrolled
December 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedDecember 30, 2022
December 1, 2022
1.9 years
October 23, 2019
December 29, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Time from discharge to first readmission.
Time from discharge to first readmission.
Time from discharge to first readmission during all readmissions due to liver cirrhosis in the 6 month trial time.
Number of readmissions
Number of readmissions within 2 years
Number of readmissions within 2 years.
Duration of readmissions
Duration of readmissions due to liver cirrhosis
Duration of readmissions due to liver cirrhosis in the 6 month trial time.
Secondary Outcomes (4)
Health related quality of life before and after intervention
The change in health related quality of life before and after intervention (6 months trial time).
Self-perceived health before and after intervention
The change in self-perceived health before and after intervention (6 months trial time).
Functional disability in work-, social-, and family life before and after intervention
The change in functional disability in work-, social-, and family life before and after intervention (6 months trial time)
Mortality
The mortality rate after 6 months, 12 months and 2 years
Study Arms (2)
Standard treatment
NO INTERVENTIONReceives standard post-discharge care with planned follow-up in the clinic for liver failure or ambulatory.
Nurse-driven post-discharge intervention
EXPERIMENTALParticipates in a nurse-driven post-discharge intervention program.
Interventions
Home visits based on the concepts of Family Nursing: The participants will receive three home visits by a nurse who is trained in the Family Nursing principles during the first 12 weeks after discharge. The home visits will comprise of: * Filling in the Chronic Liver Disease Questionnaire. * Therapeutic conversations including drawing and review of genogram and eco-map. * Information about- and help to initiate contact to relevant municipal offers. * Evidence-based information based on the patient's current problems or symptoms, base-line knowledge and receptiveness. Follow-up telephone calls: • After the first 12 weeks participants will be followed-up by telephone monthly during the following 12 weeks. Pamphlet: • All participants will receive a pamphlet with brief information regarding preventive measures and early signs of decompensation as well as relevant contact details. The pamphlet will be handed out before discharge
Eligibility Criteria
You may qualify if:
- Patients diagnosed with liver cirrhosis and one or more complications hereto during admission to the Gastro Unit, AHH. Complications include, but are not limited to: hepatic encephalopathy, infection, ascites, edema, kidney failure, upper or lower GI bleeding.
- Patients must read and understand Danish.
- Adults \>18 years.
You may not qualify if:
- When the diagnosis of liver cirrhosis is questioned with reasonable doubt or the diagnosis of liver cirrhosis is disproved by histology or relevant imaging.
- Patients with comorbidity as the primary diagnosis and where an independent rehabilitation or post-discharge program is offered, for example hip fracture, chronic obstructive pulmonary disease etc.
- Patients diagnosed with an active and invasive malignant disease.
- Residency outside the catchment area of Amager Hvidovre Hospital.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Copenhagen University Hospital, Amager Hvidovre
Copenhagen, Hvidovre, 2650, Denmark
Related Publications (1)
Barfod O'Connell M, Brodsgaard A, Matthe M, Hobolth L, Wullum L, Bendtsen F, Kimer N. A randomized controlled trial of a postdischarge nursing intervention for patients with decompensated cirrhosis. Hepatol Commun. 2024 Apr 26;8(5):e0418. doi: 10.1097/HC9.0000000000000418. eCollection 2024 May 1.
PMID: 38668732DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Malene Barfod O'Connell, RN, MScPH
Amager Hvidovre Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Allocation is blinded.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- RN, PhD student
Study Record Dates
First Submitted
October 23, 2019
First Posted
November 12, 2019
Study Start
December 1, 2019
Primary Completion
October 13, 2021
Study Completion
October 1, 2022
Last Updated
December 30, 2022
Record last verified: 2022-12